AKT1 and non-small cell lung carcinoma: In non‐small‐cell lung cancer (NSCLC), USP44 inhibits NSCLC cell growth via repressing AKT signaling through PTEN stabilization (Zhang, Tian, Zhang, Zhang, & Ma, 2019).